Biological Psychiatry

ISSN 0006-3223

Publisher: Elsevier

Related content

Volume 47, Number 12, June 2000

The serotonin transporter in the midbrain of suicide victims with major depression
pp. 1015-1024(10)
Authors: Bligh-Glover W.; Kolli T.N.; Shapiro-Kulnane L.; Dilley G.E.; Friedman L.; Balraj E.; Rajkowska G.; Stockmeier C.A.

Open-label adjunctive topiramate in the treatment of bipolar disorders
pp. 1025-1033(9)
Authors: McElroy S.L.; Suppes T.; Keck P.E.; Frye M.A.; Denicoff K.D.; Altshuler L.L.; Brown E.S.; Nolen W.A.; Kupka R.W.; Rochussen J.; Leverich G.S.; Post R.M.

Family history and symptom levels during treatment for bipolar I affective disorder
pp. 1034-1042(9)
Authors: Coryell W.; Akiskal H.; Leon A.C.; Turvey C.; Solomon D.; Endicott J.

Increased neurogenesis in a model of electroconvulsive therapy
pp. 1043-1049(7)
Authors: Madsen T.M.; Treschow A.; Bengzon J.; Bolwig T.G.; Lindvall O.; Tingstrom A.

Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: a morphometric MRI study
pp. 1056-1063(8)
Authors: Laakso M.P.; Frisoni G.B.; Kononen M.; Mikkonen M.; Beltramello A.; Geroldi C.; Bianchetti A.; Trabucchi M.; Soininen H.; Aronen H.J.

Frontal P300 decrements, alcohol dependence, and antisocial personality disorder
pp. 1064-1071(8)
Authors: Costa L.; Bauer L.; Kuperman S.; Porjesz B.; O'Connor S.; Hesselbrock V.; Rohrbaugh J.; Begleiter H.

Thrice-weekly versus daily buprenorphine maintenance
pp. 1072-1079(8)
Authors: Schottenfeld R.S.; Pakes J.; O'Connor P.; Chawarski M.; Oliveto A.; Kosten T.R.

Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial
pp. 1080-1086(7)
Authors: George T.P.; Chawarski M.C.; Pakes J.; Carroll K.M.; Kosten T.R.; Schottenfeld R.S.

Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study
pp. 1087-1090(4)
Authors: Vakili K.; Pillay S.S.; Lafer B.; Fava M.; Renshaw P.F.; Bonello-Cintron C.M.; Yurgelun-Todd D.A.

Erratum
pp. 1092-1092(1)